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Abstract: The use of three-dimensional (3D) scaffolds is recognized worldwide as a valuable 
biomedical approach for promoting tissue regeneration in critical-size bone defects. Over the last 50 
years, bioactive glasses have been intensively investigated in a wide range of different clinical 
applications, from orthopedics to soft tissue healing. Bioactive glasses exhibit the unique capability 
to chemically bond to the host tissue and, furthermore, their processing versatility makes them 
very appealing due to the availability of different manufacturing techniques for the production of 
porous and interconnected synthetic bone grafts able to support new tissue growth over the whole 
duration of the treatment. As a novel contribution to the broad field of scaffold manufacturing, we 
report here an effective and relatively easy method to produce silicate glass-derived scaffolds by 
using, for the first time in the biomedical field, dolomite powder as a foaming agent for the 
formation of 3D bone-like porous structures. Morphological/structural features, crystallization 
behavior, and in vitro bioactivity in a simulated body fluid (SBF) were investigated. All the tested 
scaffolds were found to fulfil the minimum requirements that a scaffold for osseous repair should 
exhibit, including porosity (65–83 vol.%) and compressive strength (1.3–3.9 MPa) comparable to 
those of cancellous bone, as well as hydroxyapatite-forming ability (bioactivity). This study proves 
the suitability of a dolomite-foaming method for the production of potentially suitable bone grafts 
based on bioactive glass systems. 
Keywords: scaffold; bioactive glass; glass–ceramic; biomaterials; bioceramics; porosity; bioactivity; 
bone tissue engineering; foaming; sustainable materials 
 
1. Introduction 
Implantation of three-dimensional (3D) porous scaffolds mimicking the trabecular architecture 
of cancellous bone is an excellent strategy to restore small- to mid-size defects of the osseous tissue 
due to fracture, bone resection surgery, or congenital diseases [1]. Using manmade biomaterials for 
making scaffolds is an advantageous approach that allows overcoming the limitations of transplant 
tissues (i.e., bone autograft, allograft, and xenograft), such as material shortage, risk of disease 
transmission from the donor to the patient, unpredictable resorption rate, and ethical/religious 
concerns [2,3]. 
Some special glass compositions exhibit the exceptional capability to bond to both bone and soft 
tissues, creating a stable interface and also promoting cell viability, healthy tissue regeneration and 
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angiogenesis [4–6]. Therefore, bioactive glasses have been widely investigated over the last decades 
and are now clinically used in the form of fine powder and granules for filling osseous defects in 
orthopedics and dentistry, composites with polyethylene in ocular surgery (porous orbital 
implants), and fiber mats for wound healing in veterinary applications [7,8]. 
Given the versatility of glass processing, bioactive glasses have also shown great promise for 
making 3D porous scaffolds according to a number of fabrication methods. The research group led 
by Larry Hench, the inventor of the 45S5 glass composition (45SiO2-24.5CaO-24.5Na2O-6P2O5 wt.%) 
[9], first proposed the foaming of sols by using surfactants as a relatively easy approach to produce 
porous scaffolds based on gel-derived bioactive glasses [10–12]. Although some of these porous 
materials (e.g., the binary glass 70S30C (70SiO2-30CaO, mol.%)) successfully reached in vivo 
experimentation (rat tibial model) and proved to actually stimulate bone regeneration [13], sol–gel 
scaffolds typically suffer from high brittleness; furthermore, the sol–gel fabrication method requires 
a careful control on process parameters such as temperature and pH to ensure reproducibility and, 
potentially, industrial scalability of the products [14]. 
Another strategy was independently pioneered in 2006 by Park et al. [15] and Chen et al. [16] 
who applied the sponge replica method to process melt-derived powders of 
CaO-CaF2-P2O5-MgO-ZnO glass and 45S5 Bioglass®, respectively, using a commercial polyurethane 
foam as a sacrificial template. In both cases, the scaffolds exhibited a trabecular pore/strut 
architecture mimicking that of cancellous bone but the compressive strength was inadequate when 
compared to the typical range of human bone tissue (2–12 MPa [17]). Since then, this method became 
very popular to obtain bone-like porous ceramics and glasses due to its relative easiness and 
inexpensiveness. Optimization of basic glass composition and/or process parameters allowed 
producing bioactive glass and glass–ceramic scaffolds with high compressive strength (up to 18 MPa 
[18,19]), making them suitable for potential use in load-bearing bone sites, too. 
Variants of this fabrication method include the use of natural or waste materials as porous 
templates, such as marine sponges [20] and stale bread [21] that were soaked in the glass powder 
suspension. If the porous template is immersed into a sol, hierarchical gel-derived scaffolds with 
multiscale macro-mesoporosity can be produced; for this purpose, not only the conventional 
open-cell polyurethane sponge [22] but also more unusual natural templates such as mushroom 
stalk [23] and cattail stem [24] have been experimented. 
However, if high mechanical properties of the scaffold are required, space holder methods are 
usually preferred. In this technique, temporary material (i.e., the space holder) is mixed with the 
glass particles and devised as a sacrificial pore former for scaffolds. The use of polyethylene particles 
[25] and rice husk [26] allow obtaining strong scaffolds that are potentially suitable for use in 
high-load-bearing defect sites or even for the replacement of cortical bone; on the other hand, these 
porous implants typically suffer from low pore interconnectivity, which limits the permeation of 
biological fluids, cell colonization, and vascularization with obvious impairment of osteointegration. 
Implementation of additive manufacturing techniques (AMTs) has recently opened new 
horizons in the fabrication of bioactive glass and ceramic scaffolds [27]. AMTs allow accurate 
control, tailoring, and reproducibility of scaffold features and pore/strut architecture, as well as an 
easy scalability to the industrial level [28]. Albeit the equipment for selective laser sintering [29] and 
stereolithography [30] still requires high investment costs, relatively affordable 3D printers are 
available on the market and can be customized on demand or in-house [31]. Furthermore, different 
materials (e.g., glass and polymers [32]) can be simultaneously processed by using 3D printing 
methods, thus obtaining composite scaffolds with finely tunable physico-chemical properties. 
In most cases, however, scaffolds produced by AMTs exhibit a grid-like arrangement of 
macro-channels that do not properly mimic the trabecular architecture of cancellous bone [33,34]; 
on the contrary, sponge replication or foaming methods allow researchers to obtain bone-like 
porous structures. 
In the present work, we propose a new method to produce foam-like silicate scaffolds based on 
a melt-derived SiO2-Na2O-K2O-MgO-CaO-P2O5 glass by using dolomite as a foaming agent. 
Dolomite was proved suitable as a foaming agent to fabricate porous glasses from waste materials 
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[35]; however, to the best of our knowledge, its use was not reported so far for the fabrication of 
biomedical scaffolds. The foaming process involves the thermal decomposition of dolomite 
associated with CO2 production while small amounts of additional calcium and magnesium are 
incorporated in the glass-derived foam. In this regard, the choice of dolomite as a foaming agent is 
appropriate for the intended application as Ca2+ and Mg2+ ions are physiologically involved in bone 
metabolism and, when released from bioactive glasses, are known to stimulate osteoblasts towards 
a path of regeneration and self-repair [36]. 
2. Materials and Methods 
2.1. Glass Production 
The silicate glass used for scaffold fabrication is called 47.5B 
(47.5SiO2-10Na2O-10K2O-10MgO-20CaO-2.5P2O5 mol.%) [37] and was already reported to be suitable 
to make robocast porous structures for biomedical applications due to its favourable sintering 
behaviour and bioactive properties [38]. The glass was obtained by melting a homogeneous mix of 
the powdered precursors (SiO2, Na2CO3, K2CO3, (MgCO3)4·Mg(OH)2·5H2O, CaCO3 and Ca3(PO4)2, 
Sigma-Aldrich, St. Louis, MO, USA) up to 1500 °C in a platinum crucible. The glass was cast in water 
to obtain a “frit” and then milled by a zirconia ball miller (Pulverisette 0, Frtisch, Idar-Oberstein, 
Germany). Finer glass powders were eventually obtained after sieving (stainless steel sieve, Giuliani 
Technologies Srl, Turin, Italy; mesh 32 μm) and then used for further processing. 
2.2. Scaffold Fabrication 
Porous scaffolds were fabricated by using 47.5B glass as the main precursor and commercial 
dolomite from Dehkanabad deposit (Uzbekistan) (chemical composition (wt.%): 30.02 CaO, 19.63 
MgO, 2.74 SiO2, 0.39 Al2O3, 0.27 Na2O, 0.10 K2O, 0.15 P2O5, 0.39 SO3, 0.01 MnO, 45.40 CO2, 0.90 others) 
as the foaming agent. In order to choose an appropriate content of the ingredients in the batch and 
decide on processing parameters, we referred to a previous study [35] that dealt with the foams 
based on sheet glass/fly ash composition with up to 5 wt.% of dolomite addition. Thus, considering 
the fact that appreciable foaming efficiency might be achieved at relatively low temperatures (e.g., 
800 C) with just 2 wt.% of dolomite incorporation [35], the formulation in the current investigation 
was decided to include 98 wt.% of 47.5B glass powder and 2 wt.% of dolomite (Table 1). 
Experimental batches were prepared by dry mixing glass and dolomite particles in a planetary mill 
for 30 min. The thoroughly mixed batches were placed into cylindrical stainless steel molds with a 
diameter and height of 10 mm and 15 mm, respectively. Heat treatment was undertaken in an 
electrically heated furnace (Carbolite type 3216 box furnace, Carbolite, Sheffield, UK) in air at 800 C 
and 850 C for 30 min (heating rate of 5 C min−1); the obtained samples were referred to as D-800 
and D-850 scaffolds, respectively. After cooling to room temperature, the scaffolds were removed 
from the molds and subjected to further investigations. 
2.3. Characterizations 
The distribution of glass particle sizes (vol.% vs. particle diameter) was assessed by a powder 
size analyzer (LS230, Beckam Coulter Corporation, Indianapolis, IN, USA). 
The porous scaffolds were investigated from morphological and microstructural viewpoints. 
Field-emission scanning electron microscopy (FE-SEM) images were acquired (FE-SEM SupraTM 40, 
Zeiss, Oberkochen, Germany) in order to assess the outcome of the foaming and sintering processes 
in terms of size of the structural features (pores and struts) and particle consolidation. The samples 
were sputter-coated with chromium before undergoing FE-SEM analysis and inspected at a voltage 
of 15 kV. 
Crystallization of 47.5B scaffolds due to thermal treatment was investigated by X-ray diffraction 
(XRD; X’Pert Pro PW3040/60 diffractometer, PANalytical, Eindhoven, Netherlands). The analysis 
was performed varying the 2θ angle from 10° to 70°; the voltage was set at 40 kV and the filament 
current at 30 mA. Bragg–Brentano camera geometry was used, including Cu Kα incident radiation 
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(λ = 0.15405 nm). Data were acquired fixing the step counting time at 1 s and the step size at 0.02°. 
The scaffold was ground into powder prior to undergoing XRD investigation. Identification of 
crystalline phases was carried out by using X’Pert HighScore software 2.2b (PANalytical, 
Eindhoven, The Netherlands) equipped with the PCPDFWIN database. 
The total porosity P (vol.%) of the scaffolds was assessed in quintuplicate by density 
measurements through the calculation of the mass-to-volume ratio (ρ: apparent density; ρ0: bulk 
density) [39]: 
ܲ = ൬1 −
ߩ
ߩ଴
൰ × 100. (1) 
The samples were mechanically tested under compressive loads (MTS Model 43, MTS, Eden 
Prairie, MN, USA; cell load 5 kN; cross-head speed 1 mm/min). The compressive strength σc (MPa) 
was calculated as the ratio between the maximal load observed LM (N) and the resistant cross-section 
Ar (mm2), which was measured for each sample by using digital calipers: 
ߪ௖ =
௅ಾ
஺ೝ
. (2) 
The results were expressed as mean ± standard deviation assessed on five specimens, which 
were polished prior to the test by using SiC grit paper. 
The bioactive properties of scaffolds were assessed upon soaking in a simulated body fluid 
(SBF), which was prepared according to the protocol reported by Kokubo and Takadama [40]. In 
vitro bioactivity tests were performed by immersing the scaffolds in SBF at 37 °C up to 7 days in 
static conditions. A mass-to-volume ratio of 1.5 mg/mL was used, as suggested in a previous study 
by the Technical Committee 4 (TC04) of the International Commission on Glass (ICG) [41]. The 
solution was completely replaced with fresh SBF every 48 h in order to simulate fluid circulation in 
physiological conditions and the pH was daily monitored by using a digital pH-meter. At the end of 
the experiment, the samples were gently rinsed with distilled water, left to dry overnight at 37 °C in 
an incubator and stored in a sealed plastic box before undergoing morphological and compositional 
investigation (FE-SEM equipped with energy dispersive spectroscopy (EDS)). 
3. Results and Discussion 
The particle size distribution of glass powder used in this work is shown in Figure 1; mean 
particle size and specific surface area of glass and dolomite powders are reported in Table 1. 
 
Figure 1. Particle size distribution of 47.5B glass powder (sieved below 32 μm) used for scaffold 
manufacturing. 
Glass-based scaffolds were produced for the first time by using dolomite powders 
(CaMg(CO3)2) as a foaming agent to obtain a porous and interconnected 3D structure for potential 
bone replacement in small- to mid-size bone defects. 
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The open-cell architecture obtained in this study was the result of the formation of gaseous CO2 
upon sintering at 800 °C and 850 °C, which is one of the reaction products of the thermal 
decomposition of CaMg(CO3)2. 
Table 1 summarizes the properties of the precursors used for the preparation of the 47.5B-based 
foams. 
Table 1. Summary of physical properties of precursors used for the production of the foams. 
Precursor 
(Powder) 
Amount in the 
Scaffold 
(wt.%) 
Particle Mean 
Size 
(µm) 
Density 
(g/cm3) 
Specific Surface 
Area 
(m2/g) 
47.5B Glass 98 16.57 2.64 0.638 
Dolomite 2 12.79 2.86 0.834 
In previous studies, DTA analysis performed on CaMg(CO3)2 revealed two endothermic peaks, 
located at 800 °C and 890 °C and associated, respectively, to the decomposition of magnesium 
carbonate (Equation 3) and calcium carbonate (Equation 4) [35,42]: 
CaMg(COଷ)ଶ ↔ CaCOଷ + MgO + COଶ (3) 
CaCOଷ ↔ CaO + COଶ. (4) 
The final reaction products deriving from the thermal decomposition of CaMg(CO3)2—i.e., CaO, 
MgO and CO2—were found to play an important role both in the definition of the compositional 
features and in the formation of the porous structure of the scaffolds: in fact, while CaO and MgO 
entered the glass network, gaseous CO2 could act as a foaming agent. 
It is worth pointing out that, from a biological point of view, both Ca and Mg are strongly 
beneficial for bone regeneration. Specifically, Ca is known to increase osteoblast proliferation, 
differentiation, and extracellular matrix (ECM) mineralization, while triggering the secretion of 
growth factors, i.e., IGF-I and IGF-II, which are fundamental for bone metabolism [36]. Moreover, it 
should be considered that additional amounts of Ca will result in a further increase in the Ca/P ratio 
in the glass composition, thus positively affecting the bioactive potential of the glass, likewise to 
what was observed in the first bioactive composition 45S5, characterized by a high Ca/P ratio and an 
exceptional bioactive potential [9]. Furthermore, there is experimental evidence proving that MgO 
has a positive effect on cell adhesion because of the beneficial interaction between integrins (cell 
membrane proteins) and magnesium ions [36]. 
FE-SEM images of the cross-sectional fracture surfaces of D-800 and D-850 scaffolds are 
displayed in Figure 2. These morphological investigations show that both D-800 and D-850 scaffolds 
exhibited a quite homogeneous distribution of large macropores in their whole volume, without any 
apparent preferential orientation. This is consistent with the results reported by Fernandes et al. [35], 
who created isotropic porous interconnected structures from waste glass by using dolomite as a 
foaming agent. Small closed pores deriving from the foaming process can also be observed in the 
scaffold solid part (struts and walls), which is nonetheless well-densified. 
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Figure 2. FE-SEM images of dolomite-foamed scaffolds D-800 (a-b-c) and D-850 (d-e-f) at different 
magnifications. 
Interestingly, the typical bubble-like architecture resulting from the dolomite-foaming method 
(Figure 2) exhibits a strong similarity to that of traditional sol–gel glass scaffolds which are foamed 
by using a surfactant [10,43,44]. In general, interconnected spheroidal pores ranging from 100 μm to 
250 μm with inter-pore windows up to 50 μm can be observed in Figure 2. These porous 
biomaterials are therefore suitable for possible use in bone repair applications, for which scaffolds 
with a minimum pore size of 100 μm are typically recommended [45]. It is worth noting that the 
scaffolds sintered at the higher temperature (D-850) exhibited smaller inter-pore channels and lower 
inter-pore connectivity due to the higher apparent density and porosity reduction achieved by 
increasing the sintering temperature. This is confirmed by porosity evaluation through gravimetric 
method, which revealed a total pore content of 83.1 ± 2.2 vol.% and 65.5 ± 7.1 vol.% for D-800 and 
D-850 samples, respectively. In both cases, scaffold porosity still is comparable to the typical range of 
human trabecular bone (50–90 vol.%) [46]. 
Apart from the characteristic elements of the base glass composition (Mg, Ca, Si, Na, P, K, and 
O), EDS analysis revealed the presence of a non-negligible amount of carbon (>6 wt.%) in both D-800 
and D-850 scaffolds, which might be attributed to an incomplete decomposition of dolomite upon 
thermal treatment. 
Figure 2c,f, displaying the presence of crystalline phases, suggests that devitrification occurred 
upon sintering at both 800 °C and 850 °C. This is consistent with the results reported by Fiume et al. 
[47] in a previous work, where the sinter-crystallization of 47.5B glass was studied in detail. 
Specifically, DTA analysis carried out on 47.5B glass powder at heating rates ranging from 10 to 40 
°C/min revealed the presence of an exothermic peak in the range of 765–848 °C [47]. As the onset 
crystallization temperature (Tx) and peak crystallization temperature (Tp) typically increase with the 
heating rate, it is reasonable to predict a shift of the position of Tx and Tp towards lower temperatures 
due to the lower heating rate used in the present study for scaffold sintering (5 °C min−1), thus 
further justifying the nucleation of crystalline species on the surface of the materials. 
XRD analyses performed on CaMg(CO3)2 powders, as-quenched 47.5B glass, D-800 and D-850 
powdered scaffolds are shown in Figure 3. 
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Figure 3. XRD patterns of pure dolomite (black), 47.5B glass (grey), D-800 (red) and D-850 (blue) 
powdered scaffolds. 
Consistently with FE-SEM observations, XRD patterns referred to in D-800 and D-850 scaffolds 
showe the presence of diffraction peaks, associated with a single crystalline phase Na4Ca4(Si6O18) 
(ref. code: 01-079-1089), in agreement with what our previous study reported about bread-derived 
glass–ceramic scaffolds sintered at 750 °C [21]. Interestingly, the same sodium–calcium silicate phase 
(combeite-type phase) was also reported by other authors [48,49] to form above 550 °C in partially 
crystallized 45S5 Bioglass®, which is the common reference among bioactive glasses and glass–
ceramics in terms of biocompatibility and bioactivity. On the other hand, the as-quenched 47.5B 
glass showed the typical XRD pattern of an amorphous material, characterized by a broad halo in 
the range 25°–35° (Figure 3). Furthermore, a direct comparison between the XRD pattern of dolomite 
(foaming agent) and those of D-800 and D-850 scaffolds allowed us to detect the presence of the 
main peak of CaMg(CO3)2 in the diffraction patterns of the sintered scaffolds at 2θ = 31.2°. The 
presence of residual dolomite explains the detection of carbon in the elemental analysis of scaffolds 
performed by EDS. 
Full decomposition of dolomite could be achieved by applying a thermal treatment above 850 
°C; however, it is strongly believed that sintering at higher temperatures might be an inconvenient 
strategy for the intended purpose. In fact, considering the properties that bioactive glass-based 
scaffolds for bone tissue engineering should have, the proper balance of good 
structural/morphological features, sintering, crystallization behavior, and hydroxyapatite 
(HA)-forming ability is considered a crucial point in order to guarantee good performances over the 
whole duration of the clinical treatment. Higher sintering temperatures, in fact, might cause an 
excessive increase in the density of the structure, which would become too high as compared to the 
reference range of human trabecular bone [50] reported in Table 2. As a consequence, porosity 
would be significantly reduced, too, if sintering is performed at higher temperatures. According to 
these considerations, T = 850 °C was deliberately selected as the maximum sintering temperature in 
this study. The biocompatibility of 47.5B-derived glass–ceramic materials was demonstrated 
elsewhere using fibroblasts [37]; further studies of cytocompatibility deserve to be performed on the 
foamed scaffolds that might contain small residual amounts of dolomite. In this regard, it is worth 
mentioning that the biocompatibility and osteogenic potential of dolomite were previously studied 
in a rat calvarial model by Moreschi et al. [51], who observed a moderate inflammatory response 
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with no osteoconductive activity. However, despite this apparently negative result, the bone repair 
process appeared to be favored in the presence of dolomite compared to the negative dolomite-free 
control [51]. 
Figure 4 shows a couple of examples of stress–strain curves related to D-800 (Figure 4a) and 
D-850 (Figure 4b) scaffolds. 
 
Figure 4. Stress–strain (σ-ε) curve of dolomite-foamed D-800 (a) and D-850 scaffolds (b). 
In both cases, the curves are characterized by the typical trend of a cellular ceramic material, 
with several peaks associated to multiple fractures that occurred upon compression until collapse 
was achieved by brittle crushing, according to the Ashby’s model [52]. As a result of the compressive 
test, the scaffolds lost their structural integrity and were reduced in small fragments; the mechanical 
test was interrupted before starting the compression of fractured foams, which would have been 
associated with densification and misleading increase of the stress [52]. 
A summary of the structural features of dolomite-foamed scaffolds produced in this study 
compared to the typical reference ranges of human trabecular bone is provided in Table 2. 
Table 2. Summary of major physical and structural parameters of dolomite-foamed scaffolds. 
Sample 
Apparent Density 
(g/cm3) 
Porosity 
(vol.%) 
Compressive Strength/σc (MPa) 
Trabecular Bone 0.18–0.56 [50] 50–90 [46] 0.1–16.0 [46] 
D-800 0.45 ± 0.050 83.1 ± 2.2 1.3 ± 0.4 
D-850 0.91 ± 0.17 65.5 ± 7.1 3.9 ± 0.9 
Apart from the previously discussed density levels, which are comparable to the reference 
values reported for human trabecular bone, both D-800 and D-850 scaffolds exhibited porosity and 
compressive strength values potentially suitable for bone tissue engineering applications. It is 
reasonable to attribute the better σc of D-850 scaffolds (3.9 ± 0.9 MPa) to the higher densification of 
the struts obtained upon sintering, resulting in a consequent decrease of the porosity of the foams. 
Despite the compressive tests performed on D-800 scaffolds yielding σc = 1.3 ± 0.4 MPa, which is one 
third that of D-850 scaffolds, this value is definitely above the lower limit of human trabecular bone 
(0.1–16 MPa [46]) and remarkably higher than the results reported for foam-replicated 45S5 
Bioglass® scaffolds (0.2–0.4 MPa) [16]. 
As regards in vitro bioactivity tests, the variation of pH as a function of the soaking time in SBF 
is plotted in Figure 5a. 
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Figure 5. Bioactivity tests in simulated body fluid (SBF): pH variation as a function of the immersion 
time (a); FE-SEM micrographs of the surface of D-800 (b-c-d) and D-850 (e-f-g) scaffolds after 
immersion in SBF for 2, 7, and 14 days; example of EDS spectrum of the newly formed surface layer 
on D-850 sample after seven days in SBF (h). 
The curves obtained for D-800 and D-850 scaffolds are characterized by the same trend: all the 
ramps between each time point indicate the increase of pH associated with the release of ions from 
the surface of the scaffold to the solution, consistent with the in vitro bioactivity mechanism typical 
of silica-based bioactive glasses [53]. The drop of pH observed every 48–72 h, instead, was due to the 
complete replacement of the solution, which was performed to simulate fluid recirculation in 
physiological conditions. 
No problems of pH-related toxicity induced by the materials were forecast, as the maximum 
value of pH reached upon soaking was around 7.7 for both scaffolds. Such a pH increase could even 
be beneficial to the activity of osteoblasts that are typically stimulated in a mildly alkaline 
environment [54]. 
In vitro bioactivity tests in SBF revealed that the scaffolds possessed a good HA-forming ability, 
which was not apparently affected by the high sintering temperatures and the devitrification of the 
material (foam). After just 48-h immersion, the surface appeared to be covered by a thin layer of HA, 
below which a cracked reaction layer of silica gel was clearly visible (Figure 5b,e). Small globular 
aggregates were observed also onto the inner surface of the pores, suggesting that the fluid properly 
permeated the whole volume of the 3D structure thanks to the open-cell architecture achievable by 
the manufacturing method here presented. 
An increasing number of globular agglomerates were observed after seven-day immersion 
(Figure 5c,f) as proof of the continuous ion exchange between the glass and the solution, and the 
progress of the bioactivity mechanism over time. 
After two weeks, the surface of the scaffolds appeared to be completely covered by a 
homogeneous layer of globular HA characterized by its typical cauliflower morphology (Figure 
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5d,g). Semi-quantitative EDS analyses of the scaffold surfaces after immersion in SBF for 14 days 
yielded Ca/P molar ratios of 1.60 ± 0.04 and 1.56 ± 0.06 (calculated on five sites) for D-800 and D-850 
samples, respectively. These values are close to that of stoichiometric HA (1.67), thus indicating an 
advanced stage of the conversion reaction of the glass surface to HA, which might result in a better 
interaction between the scaffold and the host tissue due to the higher similarity to the calcium–
phosphate mineral phase of bone. EDS analysis revealed that the Si peak (typical of the 
47.5B-derived materials) disappeared just after one-week immersion in SBF, while the peaks of Ca 
and P are well visible (Figure 5h), thus indicating that the surface of the scaffolds was completely 
covered by a relatively thick calcium phosphate layer (the peaks of chromium are due to metal 
coating prior to the analysis, the small peaks of Na, Mg, and Cl can be associated to traces of salts 
formed during immersion). 
Formation of an HA layer on the surface of biomaterials is commonly considered as a key 
requirement to allow interfacial bonding with bone after implantation in the living body as 
osteoblasts will attach and proliferate on this calcium–phosphate layer, producing new bone [55]. 
Figure 5 suggests that the pore interconnectivity still persisted during immersion in SBF, regardless 
of the growth of the HA layer that tends to slightly reduce the macropore size. This is consistent with 
previous studies on macroporous glass scaffolds reporting that the thickness of the surface HA layer 
can reach 20-30 μm, yet allowing scaffold permeation by bio-fluids and cells [56,57]. 
As a further proof of the good HA-forming ability of the scaffolds, XRD analyses were carried 
out on D-800 and D-850 samples immersed up to 7 and 14 days in SBF (Figure 6) and compared to 
the patterns of the starting materials. 
 
Figure 6. XRD patterns after immersion in SBF at different time points related to D-800 (a) and D-850 
(b) scaffolds. CP = crystalline phase (Na4Ca4(Si6O18)) of sintered glass-ceramic scaffold; D = residual 
dolomite; SG = halo associated to the silica gel layer; HA = hydroxyapatite. 
The XRD patterns related to the two analyzed systems evolved following a comparable trend. 
The analysis revealed that the diffraction peaks identifying the scaffold crystalline phase were nearly 
no longer visible after one-week immersion in SBF, while a broad peak was detected at around 32° 
((211) major reflection of HA) as well as the presence of a halo between 20°–30° associated to the 
formation of the reaction layer of silica gel. After two-week immersion in SBF, the major peak of HA 
became a bit shaper and a secondary peak appeared at 26.2°, corresponding to the (002) reflection of 
HA [58]. 
Collectively, the results of EDS, FE-SEM, and XRD analyses obtained from D-800/D-850 
scaffolds after in vitro bioactivity tests suggested no significant influence of the sintering 
Materials 2020, 13, 628 11 of 13 
 
temperature on the HA-forming ability of samples, as HA deposition kinetics and morphological 
features were comparable in both systems analyzed. 
4. Conclusions 
In this work, dolomite foaming was implemented for the first time to obtain 3D porous 
bioactive glass-based scaffolds for medical applications in bone tissue engineering. This strategy 
represents an interesting and novel example of how waste material (e.g., dolomite powder from 
stone processing) could be used to fabricate high-added-value products for advanced applications 
like biomedical glass-derived foams. Morphological, structural, and bioactive properties of the 
obtained glass–ceramic scaffolds were found to be potentially suitable for the intended purpose. 
Increase of the sintering temperature from 800 °C to 850 °C led to a favorable increase in the 
mechanical properties of the structures under compressive loads and did not affect the HA-forming 
ability of the material in SBF. Further studies could be carried out to determine the influence of 
residual dolomite on cellular viability and metabolism. Taken together, these results are promising 
and open up new possibilities in the field of scaffold manufacturing for bone tissue applications. 
Author Contributions: Conceptualization, D.T. and F.B.; methodology, D.T. and F.B.; software, E.F. and F.B.; 
validation, F.B.; formal analysis, F.B.; investigation, E.F., D.T. and F.B.; resources, D.T., G.U., E.V. and F.B.; data 
curation, E.F. and F.B.; writing—original draft preparation, E.F. and F.B.; writing—review and editing, E.F., 
D.T., G.U., E.V. and F.B.; visualization, E.F. and F.B.; supervision, E.V. and F.B. All authors have read and 
agreed to the published version of the manuscript. 
Funding: This research received no external funding. 
Conflicts of Interest: The authors declare no conflict of interest relevant to this article. 
References 
1. Baino, F.; Marchi, J.; Fiume, E.; Barberi, J.; Kargozar, S. Processing methods for making porous bioactive 
glass - based scaffolds — A state - of - the - art review. Int. J. Appl. Ceram. Technol. 2019, 16, 1762–1796. 
2. Campana, V.; Milano, G.; Pagano, E.; Barba, M.; Cicione, C.; Salonna, G.; Lattanzi, W.; Logroscino, G. Bone 
substitutes in orthopaedic surgery: from basic science to clinical practice. J. Mater. Sci. Mater. Electron. 2014, 
25, 2445–2461. 
3. Lasanianos, N.G.; Kanakaris, N.K.; Giannoudis, P.V. Current menagment of long bone large segmental 
defects. Orthop. Trauma 2010, 24, 149–163. 
4. Rahaman, M.N.; Day, D.E.; Bal, B.S.; Fu, Q.; Jung, S.B.; Bonewald, L.F.; Tomsia, A.P. Bioactive glass in 
tissue engineering. Acta Biomater. 2011, 7, 2355–2373. 
5. Baino, F.; Novajra, G.; Miguez-Pacheco, V.; Boccaccini, A.R.; Vitale-Brovarone, C. Bioactive glasses: Special 
applications outside the skeletal system. J. Non-Crystalline Solids 2016, 432, 15–30. 
6. Kargozar, S.; Baino, F.; Hamzehlou, S.; Hill, R.G.; Mozafari, M. Bioactive Glasses: Sprouting Angiogenesis 
in Tissue Engineering. Trends Biotechnol. 2018, 36, 430–444. 
7. Jones, J.R.; Brauer, D.S.; Hupa, L.; Greenspan, D.C. Bioglass and Bioactive Glasses and Their Impact on 
Healthcare. Int. J. Appl. Glas. Sci. 2016, 7, 423–434. 
8. Baino, F.; Hamzehlou, S.; Kargozar, S. Bioactive glasses: Where are we and where are we going? J. Funct. 
Biomater. 2018, 9, 25. 
9. Hench, L.L. The story of Bioglass®. J. Mater. Sci. Mater. Electron. 2006, 17, 967–978. 
10. Sepulveda, P.; Jones, J.R.; Hench, L.L. Bioactive sol-gel foams for tissue repair. J. Biomed. Mater. Res. 2002, 
59, 340–348. 
11. Sepulveda, P.; Jones, J.R.; Hench, L.L. In vitro dissolution of melt-derived 45S5 and sol-gel derived 58S 
bioactive glasses. J. Biomed. Mater. Res. 2002, 61, 301–311. 
12. Jones, J.R.; Ehrenfried, L.M.; Hench, L.L. Optimising bioactive glass scaffolds for bone tissue engineering. 
Biomaterials 2006, 27, 964–973. 
13. Midha, S.; Kim, T.B.; Bergh, W.V.D.; Lee, P.D.; Jones, J.R.; Mitchell, C.A. Preconditioned 70S30C bioactive 
glass foams promote osteogenesis in vivo. Acta Biomater. 2013, 9, 9169–9182. 
14. Baino, F.; Fiume, E.; Miola, M.; Vernè, E. Bioactive sol-gel glasses: Processing, properties, and applications. 
Int. J. Appl. Ceram. Technol. 2018, 15, 841–860. 
Materials 2020, 13, 628 12 of 13 
 
15. Park, Y.-S.; Kim, K.-N.; Kim, K.-M.; Choi, S.-H.; Kim, C.-K.; LeGeros, R.Z.; Lee, Y.-K. Feasibility of 
three-dimensional macroporous scaffold using calcium phosphate glass and polyurethane sponge. J. 
Mater. Sci. 2006, 41, 4357–4364. 
16. Chen, Q.Z.; Thompson, I.D.; Boccaccini, A.R. 45S5 Bioglass®-derived glass–ceramic scaffolds for bone 
tissue engineering. Biomaterials 2006, 27, 2414–2425. 
17. Kaur, G.; Kumar, V.; Baino, F.; Mauro, J.C.; Pickrell, G.; Evans, I.; Bretcanu, O. Mechanical properties of 
bioactive glasses, ceramics, glass-ceramics and composites: State-of-the-art review and future challenges. 
Mater. Sci. Eng. C 2019, 104, 109895. 
18. Fu, Q.; Rahaman, M.N.; Bal, B.S.; Brown, R.F.; Day, D.E. Mechanical and in vitro performance of 13–93 
bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater. 2008, 4, 1854–
1864. 
19. Baino, F.; Vitale-Brovarone, C. Mechanical properties and reliability of glass–ceramic foam scaffolds for 
bone repair. Mater. Lett. 2014, 118, 27–30. 
20. Boccardi, E.; Philippart, A.; Juhasz-Bortuzzo, J.A.; Novajra, G.; Vitale-Brovarone, C.; Boccaccini, A.R. 
Characterisation of Bioglass based foams developed via replication of natural marine sponges. Adv. Appl. 
Ceram. 2015, 114, S56–S62. 
21. Fiume, E.; Serino, G.; Bignardi, C.; Verné, E.; Baino, F. Bread-derived bioactive porous scaffolds: An 
innovative and sustainable approach to bone tissue engineering. Molecules 2019, 24, 2954. 
22. Zhu, Y.; Wu, C.; Ramaswamy, Y.; Kockrick, E.; Simon, P.; Kaskel, S.; Zreiqat, H. Preparation, 
characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue 
engineering. Microporous Mesoporous Mater. 2008, 112, 494–503. 
23. Han, X.; Li, X.; Lin, H.; Ma, J.; Chen, X.; Bian, C.; Wu, X.; Qu, F. Hierarchical meso–macroporous bioglass 
for bone tissue engineering. J. Sol-Gel Sci. Technol. 2014, 70, 33–39. 
24. Ma, J.; Xiang, D.; Qu, F.; Li, X.; Bian, C.; Lin, H. Synthesis of hierarchical porous bioactive glasses for bone 
tissue regeneration. IET Nanobiotechnology 2014, 8, 216–221. 
25. Baino, F.; Verné, E.; Vitale-Brovarone, C. 3-D high-strength glass–ceramic scaffolds containing 
fluoroapatite for load-bearing bone portions replacement. Mater. Sci. Eng. C 2009, 29, 2055–2062. 
26. Wu, S.; Hsu, H.; Hsiao, S.; Ho, W. Preparation of porous 45S5 Bioglass® -derived glass ceramic scaffolds 
by using rice husk as a porogen additive. J. Mater. Sci. Mater. Med. 2009, 20, 1229–1236. 
27. Gmeiner, R.; Deisinger, U.; Schönherr, J.; Lechner, B.; Detsch, R.; Boccaccini, A.R.; Stampfl, J. Additive 
manufacturing of bioactive glasses and silicate bioceramics. J. Ceram. Sci. Technol. 2015, 6, 75–86. 
28. Nommeots-Nomm, A.; Ligorio, C.; Bodey, A.; Cai, B.; Jones, J.; Lee, P.; Poologasundarampillai, G. 
Four-dimensional imaging and quantification of viscous flow sintering within a 3D printed bioactive glass 
scaffold using synchrotron X-ray tomography. Mater. Today Adv. 2019, 2, 100011. 
29. Kolan, K.C.R.; Leu, M.C.; Hilmas, G.E.; Brown, R.F.; Vélez, M. Fabrication of 13–93 bioactive glass 
scaffolds for bone tissue engineering using indirect selective laser sintering. Biofabrication 2011, 3, 025004. 
30. Tesavibul, P.; Felzmann, R.; Gruber, S.; Liska, R.; Thompson, I.; Boccaccini, A.R.; Stampfl, J. Processing of 
45S5 Bioglass® by lithography-based additive manufacturing. Mater. Lett. 2012, 74, 81–84. 
31. Barberi, J.; Baino, F.; Fiume, E.; Orlygsson, G.; Nommeots-Nomm, A.; Massera, J.; Verné, E.; Nomm, N.- 
Robocasting of SiO2-Based Bioactive Glass Scaffolds with Porosity Gradient for Bone Regeneration and 
Potential Load-Bearing Applications. Materials 2019, 12, 2691. 
32. Yun, H.S.; Kim, S.E.; Park, E.K. Bioactive glass-poly(epsilon-caprolactone) composite scaffolds with 3 
dimensionally hierarchical pore networks. Mater. Sci. Eng. C 2011, 31, 198–205. 
33. Fu, Q.; Saiz, E.; Tomsia, A.P. Direct ink writing of highly porous and strong glass scaffolds for 
load-bearing bone defects repair and regeneration. Acta Biomater. 2011, 7, 3547–3554. 
34. Eqtesadi, S.; Motealleh, A.; Miranda, P.; Pajares, A.; Lemos, A.; Ferreira, J.M. Robocasting of 45S5 bioactive 
glass scaffolds for bone tissue engineering. J. Eur. Ceram. Soc. 2014, 34, 107–118. 
35. Fernandes, H.; Tulyaganov, D.; Ferreira, J. Preparation and characterization of foams from sheet glass and 
fly ash using carbonates as foaming agents. Ceram. Int. 2009, 35, 229–235. 
36. Hoppe, A.; Güldal, N.S.; Boccaccini, A.R. A review of the biological response to ionic dissolution products 
from bioactive glasses and glass-ceramics. Biomaterials 2011, 32, 2757–2774. 
37. Verné, E.; Bretcanu, O.; Balagna, C.; Bianchi, C.L.; Cannas, M.; Gatti, S.; Vitale-Brovarone, C. Early stage 
reactivity and in vitro behavior of silica-based bioactive glasses and glass-ceramics. J. Mater. Sci. Mater. 
Med. 2009, 20, 75–87. 
Materials 2020, 13, 628 13 of 13 
 
38. Baino, F.; Barberi, J.; Fiume, E.; Orlygsson, G.; Massera, J.; Verné, E. Robocasting of Bioactive 
SiO2-P2O5-CaO-MgO-Na2O-K2O Glass Scaffolds. J. Heal. Eng. 2019, 2019, 5153136–12. 
39. Karageorgiou, V.; Kaplan, D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005, 26, 
5474–5491. 
40. Kokubo, T.; Takadama, H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006, 27, 
2907–2915. 
41. Maçon, A.L.B.; Kim, T.B.; Valliant, E.M.; Goetschius, K.; Brow, R.K.; Day, D.E.; Hoppe, A.; Boccaccini, A.R.; 
Kim, I.Y.; Ohtsuki, C.; et al. A unified in vitro evaluation for apatite-forming ability of bioactive glasses 
and their variants. J. Mater. Sci. Mater. Electron. 2015, 26, 115. 
42. Gunasekaran, S.; Anbalagan, G. Thermal decomposition of natural dolomite. Bull. Mater. Sci. 2007, 30, 339–
344. 
43. Baino, F.; Fiume, E.; Miola, M.; Leone, F.; Onida, B.; Verné, E. Fe-doped bioactive glass-derived scaffolds 
produced by sol-gel foaming. Mater. Lett. 2019, 235, 207–211. 
44. Poologasundarampillai, G.; Lee, P.D.; Lam, C.; Kourkouta, A.M.; Jones J.R. Compressive strength of 
bioactive sol–gel glass foam scaffolds. Int. J. Applied Glass Sci. 2016, 7, 229-237.. 
45. Hing, K.A. Bioceramic bone graft substitutes: Influence of porosity and chemistry. Int. J. Appl. Ceram. 
Technol. 2005, 2, 184–199. 
46. Gerhardt, L.-C.; Boccaccini, A.R. Bioactive glass and glass-ceramic scaffolds for bone tissue engineering. 
Materials 2010, 3, 3867–3910. 
47. Fiume, E.; Verné, E.; Baino, F. Crystallization behavior of SiO2–P2O5–CaO–MgO–Na2O–K2O bioactive glass 
powder. Biomed. Glas. 2019, 5, 46–52. 
48. Filho, O.P.; Latorre, G.P.; Hench, L.L. Effect of crystallization on apatite-layer formation of bioactive glass 
45S5. J. Biomed. Mater. Res. 1996, 30, 509–514. 
49. Bretcanu, O.; Chatzistavrou, X.; Paraskevopoulos, K.; Conradt, R.; Thompson, I.; Boccaccini, A.R. Sintering 
and crystallisation of 45S5 Bioglass® powder. J. Eur. Ceram. Soc. 2009, 29, 3299–3306. 
50. Morgan, E.F.; Bayraktar, H.H.; Keaveny, T.M. Trabecular bone modulus–density relationships depend on 
anatomic site. J. Biomech. 2003, 36, 897–904. 
51. Moreschi, E.; Hernandes, L.; Dantas, J.A.; Da Silva, M.A.R.C.P.; Casaroto, A.R.; Bersani-Amado, C.A. 
Effect of dolomite on the repair of bone defects in rats: Histological study. Histol. Histopathol. 2010, 25, 
1547–1556. 
52. Gibson, L.J.; Ashby, M.F. Cellular Solids: Structure and Properties. Cambridge University Press: Cambridge, 
UK, 1999. 
53. Greenspan, D.C. Bioactive glass: Mechanisms of bone bonding. Tandläkartidningen Ǻrk 1999, 91, 1–32. 
54. Kohn, D.H.; Sarmadi, M.; I Helman, J.; Krebsbach, P.H. Effects of pH on human bone marrow stromal cells 
in vitro: Implications for tissue engineering of bone. J. Biomed. Mater. Res. 2002, 60, 2–9. 
55. Mozafari, M.; Banijamali, S.; Baino, F.; Kargozar, S.; Hill, R.G. Calcium carbonate: Adored and ignored in 
bioactivity assessment. Acta Biomater. 2019, 91, 35–47. 
56. Renghini, C.; Komlev, V.; Fiori, F.; Verné, E.; Baino, F.; Vitale-Brovarone, C. Micro-CT studies on 3-D 
bioactive glass–ceramic scaffolds for bone regeneration. Acta Biomater. 2009, 5, 1328–1337. 
57. Renghini, C.; Giuliani, A.; Mazzoni, S.; Brun, F.; Larsson, E.; Baino, F.; Vitale-Brovarone, C. Microstructural 
characterization and in vitro bioactivity of porous glass-ceramic scaffolds for bone regeneration by 
synchrotron radiation X-ray microtomography. J. Eur. Ceram. Soc. 2013, 33, 1553–1565. 
58. Ungureanu, D.A.N.N.; Angelescu, N.; Ion, R.M.; Stoian, E.V.; Rizescu, C.Z. Synthesis and Characterization 
of Hydroxyapatite Nanopowders by Chemical Precipitation. In Proceedings of 3rd WSEAS International 
Conference on Nanotechnology, Cambridge, UK, 20–22 February 2011; 296–301. 
 
 
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
